Home
User Guide
What's in a MalaCard Search Guide Our Sources
Analysis Tools
GeneCards GeneAnalytics GeneAlaCart PathCards VarElect TGex
News and Views Disease Lists/Categories
About
About MalaCards Datasets Our Publications Weizmann Institute LifeMap Discovery® Terms of Use MalaCards Team
MCID: HYP540
MIFTS: 40

Hypertension, Diastolic

Categories: Genetic diseases
Genes Variations Tissues Related diseases Publications Pathways Symptoms & Phenotypes Drugs
Sources

Aliases & Classifications for Hypertension, Diastolic

About this section

MalaCards integrated aliases for Hypertension, Diastolic:

Name: Hypertension, Diastolic 56
Hypertension, Diastolic, Resistance to 56 29 13 6 39
Diastolic Hypertension 54 71

Characteristics:

OMIM:

56
Inheritance:
autosomal dominant


HPO:

31
hypertension, diastolic:
Inheritance autosomal dominant inheritance


Classifications:

MalaCards categories:
Global: Genetic diseases
See all MalaCards categories (disease lists)


External Ids:

OMIM 56 608622
MedGen 41 C1837739
SNOMED-CT via HPO 68 263681008
UMLS 71 C0235222
Sources

Summaries for Hypertension, Diastolic

About this section
OMIM : 56 Hypertension is a significant risk factor for cardiac and renal disease, arteriosclerosis, retinopathy, and stroke. Systolic hypertension reflects an increase in the force of cardiac contraction, whereas diastolic hypertension reflects an increase in peripheral vascular resistance. Normalization of blood pressure is associated with reductions in morbidity and mortality related to end-organ damage. (608622)

MalaCards based summary : Hypertension, Diastolic, also known as hypertension, diastolic, resistance to, is related to systolic heart failure and diastolic heart failure. An important gene associated with Hypertension, Diastolic is KCNMB1 (Potassium Calcium-Activated Channel Subfamily M Regulatory Beta Subunit 1), and among its related pathways/superpathways are cGMP-PKG signaling pathway and Oxytocin signaling pathway. The drugs Angiotensin II and Amlodipine have been mentioned in the context of this disorder. Affiliated tissues include heart, kidney and endothelial, and related phenotypes are elevated diastolic blood pressure and renal/urinary system

Sources

Related Diseases for Hypertension, Diastolic

About this section

Diseases related to Hypertension, Diastolic via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 125)
# Related Disease Score Top Affiliating Genes
1 systolic heart failure 30.1 NPPA ACE
2 diastolic heart failure 29.9 REN NPPA ACE
3 carotid stenosis 29.5 REN ACE
4 pulmonary hypertension 29.3 REN NPPA ACE
5 renovascular hypertension 29.2 REN NPPA ACE
6 hypertensive heart disease 29.2 REN NPPA ACE
7 congestive heart failure 29.2 REN NPPA ACE
8 acute myocardial infarction 29.2 REN NPPA ACE
9 cerebrovascular disease 29.2 REN NPPA ACE
10 stroke, ischemic 29.1 REN NPPA ACE
11 chronic kidney disease 29.1 REN NPPA ACE
12 pheochromocytoma 28.9 REN NPPA ACE
13 hypertension, essential 27.8 REN NPPA KCNMB1 KCNMA1 GGT1 ACE
14 episodic ataxia, type 4 10.3 KCNMB1 KCNIP1
15 episodic ataxia, type 3 10.3 KCNMB1 KCNIP1
16 vasculogenic impotence 10.1 NPPA ACE
17 anterolateral myocardial infarction 10.1 NPPA ACE
18 idiopathic edema 10.1 NPPA ACE
19 tuberculous meningitis 10.1 NPPA GGT1
20 idiopathic hypercalciuria 10.0 REN NPPA
21 inappropriate adh syndrome 10.0 REN NPPA
22 familial hypertension 10.0 REN NPPA
23 twin-to-twin transfusion syndrome 10.0 REN NPPA
24 sleep apnea 10.0 REN ACE
25 renal artery obstruction 10.0 REN ACE
26 orthostatic proteinuria 10.0 REN ACE
27 cholesterol embolism 10.0 REN ACE
28 kidney papillary necrosis 10.0 REN ACE
29 generalized atherosclerosis 10.0 REN ACE
30 potter's syndrome 10.0 REN ACE
31 hypertensive encephalopathy 10.0 REN ACE
32 severe nonproliferative diabetic retinopathy 10.0 REN ACE
33 malignant essential hypertension 10.0 REN ACE
34 fibromuscular dysplasia 10.0 REN ACE
35 kidney hypertrophy 10.0 REN ACE
36 hypertensive retinopathy 10.0 REN ACE
37 cardiac tamponade 10.0 REN ACE
38 alcoholic cardiomyopathy 10.0 REN ACE
39 chronic pyelonephritis 10.0 REN ACE
40 anuria 10.0 REN ACE
41 diabetic autonomic neuropathy 10.0 REN ACE
42 pseudohyperkalemia, familial, 2, due to red cell leak 10.0 REN ACE
43 aortic valve insufficiency 10.0 REN ACE
44 vascular disease 10.0
45 microvascular complications of diabetes 3 10.0 REN ACE
46 pyelitis 10.0 REN ACE
47 renal tubular dysgenesis 10.0 REN ACE
48 intermediate coronary syndrome 9.9 REN ACE
49 autonomic nervous system disease 9.9 REN ACE
50 pericardium disease 9.9 REN ACE

Graphical network of the top 20 diseases related to Hypertension, Diastolic:



Diseases related to Hypertension, Diastolic
Sources

Symptoms & Phenotypes for Hypertension, Diastolic

About this section

Human phenotypes related to Hypertension, Diastolic:

31
# Description HPO Frequency HPO Source Accession
1 elevated diastolic blood pressure 31 HP:0005117

Symptoms via clinical synopsis from OMIM:

56
Cardiovascular Vascular:
resistance to moderate and severe diastolic hypertension

Clinical features from OMIM:

608622

MGI Mouse Phenotypes related to Hypertension, Diastolic:

45
# Description MGI Source Accession Score Top Affiliating Genes
1 renal/urinary system MP:0005367 9.1 ACE GGT1 KCNMA1 KCNMB1 NPPA REN
Sources

Drugs & Therapeutics for Hypertension, Diastolic

About this section

Drugs for Hypertension, Diastolic (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 89)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Angiotensin II Approved, Investigational Phase 4 68521-88-0, 4474-91-3, 11128-99-7 172198
2
Amlodipine Approved Phase 4 88150-42-9 2162
3
Nebivolol Approved, Investigational Phase 4 152520-56-4, 118457-14-0, 99200-09-6 71301
4
Lisinopril Approved, Investigational Phase 4 83915-83-7, 76547-98-3 5362119
5
Simvastatin Approved Phase 4 79902-63-9 54454
6
Enalaprilat Approved Phase 4 76420-72-9 6917719
7
Enalapril Approved, Vet_approved Phase 4 75847-73-3 5362032 40466924
8
Valsartan Approved, Investigational Phase 4 137862-53-4 60846
9
Ranolazine Approved, Investigational Phase 4 95635-55-5, 142387-99-3 56959
10
Ambrisentan Approved, Investigational Phase 4 177036-94-1 6918493
11 Angiotensin II Type 1 Receptor Blockers Phase 4
12 Giapreza Phase 4
13 Angiotensin Receptor Antagonists Phase 4
14 Angiotensinogen Phase 4
15 Angiotensin-Converting Enzyme Inhibitors Phase 4
16 Adrenergic beta-Agonists Phase 4
17 Protective Agents Phase 4
18 Hypolipidemic Agents Phase 4
19 Anticholesteremic Agents Phase 4
20 Hydroxymethylglutaryl-CoA Reductase Inhibitors Phase 4
21 Antimetabolites Phase 4
22 Lipid Regulating Agents Phase 4
23 Sodium Channel Blockers Phase 4
24 Diuretics, Potassium Sparing Phase 4
25
Hydrochlorothiazide Approved, Vet_approved Phase 3 58-93-5 3639
26
Benazepril Approved, Investigational Phase 3 86541-75-5 5362124
27
Guanfacine Approved, Investigational Phase 3 29110-47-2 3519
28
Trastuzumab Approved, Investigational Phase 3 180288-69-1 9903
29
Cyclophosphamide Approved, Investigational Phase 3 50-18-0, 6055-19-2 2907
30
Doxorubicin Approved, Investigational Phase 3 23214-92-8 31703
31
Docetaxel Approved, Investigational Phase 3 114977-28-5 148124
32 Darusentan Investigational Phase 3 171714-84-4
33 Natriuretic Agents Phase 3
34 Sodium Chloride Symporter Inhibitors Phase 3
35 diuretics Phase 3
36 Endothelin Receptor Antagonists Phase 3
37 Antirheumatic Agents Phase 3
38 Anti-Bacterial Agents Phase 3
39 Alkylating Agents Phase 3
40 Antineoplastic Agents, Immunological Phase 3
41 Mitogens Phase 3
42 Antibiotics, Antitubercular Phase 3
43 Antimitotic Agents Phase 3
44 Topoisomerase Inhibitors Phase 3
45
Liposomal doxorubicin Phase 3 31703
46 Immunosuppressive Agents Phase 3
47 Immunologic Factors Phase 3
48
Nitric Oxide Approved Phase 1 10102-43-9 145068
49
Resveratrol Approved, Experimental, Investigational Phase 1 501-36-0 445154
50 Grape Approved Phase 1

Interventional clinical trials:

(show all 23)
# Name Status NCT ID Phase Drugs
1 A Randomized, Double-blind, Parallel-Group Study to Evaluate the Effects of First-Line Treatment With a Free Combination of Nebivolol and Lisinopril Compared With Placebo and the Monotherapy Components on Blood Pressure in Patients With Stage 2 Diastolic Hypertension Completed NCT01218100 Phase 4 nebivolol and lisinopril (free combination);nebivolol monotherapy;lisinopril monotherapy;placebo
2 Effect of the Addition of Simvastatin to Enalapril in Hypertensive Individuals With Average Cholesterol Levels and Diastolic Dysfunction Completed NCT01061450 Phase 4 Simvastatin;Placebo
3 Valsartan Versus Amlodipine Effect on Left Ventricular Multidirectional Deformation and Adipocytokines Level in Hypertensive Patients: Speckle Tracking Echocardiography Completed NCT03990480 Phase 4 valsartan (160 mg/d);amlodipine (10 mg/d).
4 Proof of Concept Study of Ranolazine in the Treatment of Pulmonary Hypertension Associated With Diastolic Left Ventricular Dysfunction Completed NCT02133352 Phase 4 Ranolazine
5 Safety and Efficacy Trial Using Ambrisentan for Pulmonary Hypertension Associated With Congestive Heart Failure With Preserved Left Ventricular Ejection Fraction Terminated NCT00840463 Phase 4 Ambrisentan
6 A Multicenter, Group Study to Evaluate the Safety and Efficacy of Amlodipine and Benazepril Administered in Combination Compared to Amlodipine Monotherapy in Hypertensive Patients Not Adequately Controlled With Amlodipine Alone Completed NCT00171366 Phase 3 amlodipine/benazepril
7 An Eight-week Multicenter Study to Evaluate the Efficacy and Safety of the Combination of Aliskiren / HCTZ (150/25 mg and 300/25 mg) in Comparison With HCTZ 25 mg in Patients With Essential Hypertension Not Adequately Responsive to HCTZ 25 mg Monotherapy Completed NCT00387517 Phase 3 Aliskiren/HCTZ
8 An Eight-week Multicenter Study to Evaluate the Efficacy and Safety of the Combination of Aliskiren / HCTZ (300/12.5 mg and 300/25 mg) in Comparison With Aliskiren 300 mg in Patients With Essential Hypertension Not Adequately Responsive to Aliskiren 300 mg Monotherapy Completed NCT00386139 Phase 3 Aliskiren/HCTZ
9 A Phase 3 Randomized, Double-Blind, Placebo- and Active-Controlled, Multi-center, Parallel Group Study to Evaluate the Safety and Efficacy of Darusentan in Subjects With Resistant Hypertension Receiving Combination Therapy With Three or More Antihypertensive Drugs, Including a Diuretic, as Compared to Guanfacine or Placebo (Protocol DAR-312) Completed NCT00389779 Phase 3 Darusentan;Guanfacine;Darusentan Placebo
10 A Phase III, Randomized, Two-armed, Patient-outcome Assessor-data Analyzer Blinded, Parallel Active Controlled Non-Inferiority Clinical Trial Study of AryoTrust™ (Aryogen Trastuzumab ) Efficacy and Safety in Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer in Comparison to Herceptin® (Genentech/Roche) Control. Recruiting NCT03425656 Phase 3 Trastuzumab plus docetaxel (for 4 21-day cycles) after four 14-day cycles of Doxorubicin plus cyclophosphamide
11 Treatment Targets for Chronic Hypertension in Pregnancy Withdrawn NCT00194974 Phase 1, Phase 2 methyldopa;labetalol;nifedipine;clonidine
12 Mechanisms of the Relaxation Response in Elderly Hypertensives Completed NCT00913991 Phase 1
13 GRAPe Seed Extract and Ventriculovascular Investigation in Normal Ejection-Fraction Heart Failure Completed NCT01185067 Phase 1 grape seed extract (MegaNatural BP, Polyphenolics, Inc.)
14 Transcatheter Renal Denervation in Heart Failure With Normal Left Ventricular Ejection Fraction - a Safety and Efficacy Study of Irrigated Radiofrequency Catheter Unknown status NCT02115230
15 Post Operative Cognitive Recovery and Neuropsychological Complications After General Anesthesia. A Comparison Between Different Techniques of Anesthesia: A Multi-Center Observational Study Unknown status NCT00507195 Hypnotics: propofol, sevoflurane, desflurane,desflurane,midazolam
16 Observational Study in Everyday Medical Practice of the Effectiveness of Telmisartan for Treatment of Isolated Systolic Hypertension in Comparison With Systolic/Diastolic Hypertension in Patients Aged 55 or Older Completed NCT02242877 Telmisartan;Telmisartan combined with hydrochlorothiazide
17 Effects of Nebivolol on Exercise Tolerance and Left Ventricular Systolic and Diastolic Function Completed NCT01056718 Nebivolol
18 Does Treating Obstructive Sleep Apnea in Obese Canadian Youth Improve Blood Sugar Control? A Multi-Centered Prospective Cohort Study Completed NCT01116375
19 Impedance Cardiography in the Evaluation of Left Ventricular Diastolic Dysfunction in Patients With Arterial Hypertension Study (IMPEDDANS) Completed NCT03209141
20 Short Term Neurobehavioural Outcomes in Late Preterm Neonates Born to Pre Eclamptic Mothers : a Prospective Observational Study Completed NCT02443259
21 Prevalence of Thyroid Function Abnormalities in HIV-infected Patients: State of Play in 2012 Recruiting NCT03149354
22 What is the Impact of Current HIV Medication Regimens on Endothelial Dysfunction? Recruiting NCT03782142 Tenofovir;Rilpivirine;Prezcobix;Dolutegravir
23 Role of EECP Therapy in Patients With Resistant Hypertension Withdrawn NCT00953797

Search NIH Clinical Center for Hypertension, Diastolic

Sources

Genetic Tests for Hypertension, Diastolic

About this section

Genetic tests related to Hypertension, Diastolic:

# Genetic test Affiliating Genes
1 Hypertension, Diastolic, Resistance to 29 KCNMB1
Sources

Anatomical Context for Hypertension, Diastolic

About this section

MalaCards organs/tissues related to Hypertension, Diastolic:

40
Heart, Kidney, Endothelial, Thyroid, Breast, Testes, Lung
Sources

Publications for Hypertension, Diastolic

About this section

Articles related to Hypertension, Diastolic:

(show top 50) (show all 452)
# Title Authors PMID Year
1
Gain-of-function mutation in the KCNMB1 potassium channel subunit is associated with low prevalence of diastolic hypertension. 56 6
15057310 2004
2
E65 K polymorphism in KCNMB1 gene is not associated with ischaemic heart disease in Spanish patients. 6
16155733 2005
3
A longitudinal study on the relationship between shift work and the progression of hypertension in male Japanese workers. 54 61
16269958 2005
4
Effects of perindopril on elastic and structural properties of large arteries in essential hypertension. 54 61
15229761 2004
5
[The TEAM study--a study of the effectiveness and tolerance of treatment of essential hypertension with a fixed combination of trandolapril and verapamil]. 54 61
9820054 1998
6
Treatment of senile hypertension: the Fosinopril in Old Patients Study (FOPS). 54 61
9366282 1997
7
I/D polymorphism of the angiotensin-converting enzyme gene does not predict isolated systolic or systolic-diastolic hypertension in the elderly. 54 61
8733034 1996
8
Angiotensin converting enzyme inhibitors as initial monotherapy in severe hypertension. Quinapril and captopril. 54 61
1747216 1991
9
Hemodynamic and renin responses to nifedipine in renovascular hypertension. 54 61
2405611 1990
10
A robust diving response in the laboratory mouse. 61
31552491 2019
11
Hypertension, diastolic stress test, and HFpEF: Does new scoring system change something? 61
31769582 2019
12
Microvascular decompression in patients with hemifacial spasm. 61
31617334 2019
13
Prevalence of diabetes and cardio-metabolic risk factors in young men in the United Arab Emirates: A cross-sectional national survey. 61
31592445 2019
14
Hypertension and its risk factors among male adolescents in intermediate and secondary schools in Sakaka City, Aljouf Region of Saudi Arabia. 61
31417059 2019
15
Ranolazine: Multifaceted Role beyond Coronary Artery Disease, a Recent Perspective. 61
31007857 2018
16
ASSOCIATION BETWEEN COMPONENTS OF METABOLIC SYNDROME AND COGNITIVE DYSFUNCTION: CROSS-SECTIONAL STUDY AMONG THE POPULATION OF THE TURKESTAN REGION. 61
29905556 2018
17
Factors associated with residual urine volume preservation in patients undergoing hemodialysis for end-stage kidney disease in Kinshasa. 61
29554877 2018
18
Sex Differences in Heart Failure. 61
30051405 2018
19
Anthropometric and cardiometabolic risk factors in parents and child obesity in Segamat, Malaysia. 61
29106558 2017
20
Mid-term results of bilateral lung transplant with postoperatively extended intraoperative extracorporeal membrane oxygenation for severe pulmonary hypertension. 61
28329232 2017
21
Chronic obstructive pulmonary disease and atrial fibrillation: An unknown relationship. 61
28188041 2017
22
Effects of pentoxifylline on hemodynamic, hemorheological, and microcirculatory parameters in young SHRs during arterial hypertension development. 61
28722518 2017
23
Role of Ranolazine in cardiovascular disease and diabetes: Exploring beyond angina. 61
27838121 2017
24
Global longitudinal strain predicts incident atrial fibrillation and stroke occurrence after acute myocardial infarction. 61
27858918 2016
25
The Inter-rater Reliability of Echocardiographic Diastolic Function Evaluation Among Emergency Physician Sonographers. 61
27614538 2016
26
Sickle cell anemia mice develop a unique cardiomyopathy with restrictive physiology. 61
27503873 2016
27
A Randomized, Double-blind, Candesartan-controlled, Parallel Group Comparison Clinical Trial to Evaluate the Antihypertensive Efficacy and Safety of Fimasartan in Patients with Mild to Moderate Essential Hypertension. 61
27161546 2016
28
The efficacy of resveratrol in controlling hypertension: study protocol for a randomized, crossover, double-blinded, placebo-controlled trial. 61
27339453 2016
29
Correlates of Blood Pressure According to Early, On Time, and Late Maturation in Adolescents. 61
26408345 2016
30
[Hypertension Control at the Primary Health Care: A Comparison Among Portuguese Natives and Portuguese Speaking African Coutries Immigrants]. 61
27285095 2016
31
Diminazene Aceturate Improves Cardiac Fibrosis and Diastolic Dysfunction in Rats with Kidney Disease. 61
27571511 2016
32
Pathophysiological effects of different risk factors for heart failure. 61
27042319 2016
33
Valacyclovir and Acyclovir Neurotoxicity With Status Epilepticus. 61
24368610 2016
34
Genotype Correlations With Blood Pressure and Efficacy From a Randomized Phase III Trial of Second-Line Axitinib Versus Sorafenib in Metastatic Renal Cell Carcinoma. 61
25816720 2015
35
Antibodies against native and oxidized cardiolipin and phosphatidylserine and phosphorylcholine in atherosclerosis development. 61
25473948 2014
36
Perceived racial discrimination and hypertension: a comprehensive systematic review. 61
24417692 2014
37
Cardiac mechanics and ventricular twist by three-dimensional strain analysis in relation to B-type natriuretic peptide as a clinical prognosticator for heart failure patients. 61
25545637 2014
38
Transarterial treatment of congenital renal arteriovenous fistulas. 61
23810295 2013
39
Effects of add-on nebivolol on blood pressure and glucose parameters in hypertensive patients with prediabetes. 61
23551727 2013
40
Probable carvedilol-induced thrombocytopenia. 61
23515512 2013
41
Blood pressure load in adults with treated hypertension. 61
23633274 2013
42
Progression of myocardial remodeling and mechanical dysfunction in the spontaneously hypertensive rat. 61
23001837 2012
43
Analysis of various etiologies of hypertension in patients hospitalized in the endocrinology division. 61
22212439 2012
44
Prediction of individuals prone to suffer from early onset of hypertension. 61
23671955 2012
45
Aldosterone and the heart: from basic research to clinical evidence. 61
22095099 2012
46
Clinical and echocardiographic correlates of intra-atrial conduction delay. 61
21846646 2011
47
Switching patients with uncontrolled hypertension on amlodipine 10 mg to single-pill combinations of telmisartan and amlodipine: results of the TEAMSTA-10 study. 61
21955225 2011
48
Telmisartan and amlodipine single-pill combinations vs amlodipine monotherapy for superior blood pressure lowering and improved tolerability in patients with uncontrolled hypertension: results of the TEAMSTA-5 study. 61
21762357 2011
49
Increased serum S-100B and neuron specific enolase - Potential markers of early nervous system involvement in essential hypertension. 61
21130083 2011
50
Do we need a pulmonary artery catheter in cardiac anesthesia? - An Indian perspective. 61
21196671 2011
Sources

Variations for Hypertension, Diastolic

About this section

ClinVar genetic disease variations for Hypertension, Diastolic:

6 ‎‎
# Gene Name Type Significance ClinVarId dbSNP ID GRCh37 Pos GRCh38 Pos
1 KCNMB1 NM_004137.4(KCNMB1):c.193G>A (p.Glu65Lys)SNV protective 5941 rs11739136 5:169810796-169810796 5:170383792-170383792
Sources

Expression for Hypertension, Diastolic

About this section
Search GEO for disease gene expression data for Hypertension, Diastolic.
Sources

Pathways for Hypertension, Diastolic

About this section

Pathways related to Hypertension, Diastolic according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1
cGMP-PKG signaling pathway 36
Show member pathways
 11.93 NPPA KCNMB1 KCNMA1
2
Oxytocin signaling pathway 36
Show member pathways
 11.59 NPPA KCNMB1 KCNMA1
3
Agents Acting on the Renin-Angiotensin System Pathway, Pharmacodynamics 60
Show member pathways
 11.22 REN ACE
4
Nitric oxide stimulates guanylate cyclase 65
Show member pathways
 10.78 KCNMB1 KCNMA1
5
Renin secretion 36
10.76 REN NPPA KCNMA1 ACE
Sources

GO Terms for Hypertension, Diastolic

About this section

Cellular components related to Hypertension, Diastolic according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 voltage-gated potassium channel complex GO:0008076 8.8 KCNMB1 KCNMA1 KCNIP1

Biological processes related to Hypertension, Diastolic according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 potassium ion transport GO:0006813 9.43 KCNMB1 KCNMA1 KCNIP1
2 response to calcium ion GO:0051592 9.37 KCNMB1 KCNMA1
3 potassium ion transmembrane transport GO:0071805 9.33 KCNMB1 KCNMA1 KCNIP1
4 amyloid-beta metabolic process GO:0050435 9.32 REN ACE
5 angiotensin maturation GO:0002003 8.96 REN ACE
6 regulation of blood pressure GO:0008217 8.8 REN NPPA ACE

Molecular functions related to Hypertension, Diastolic according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 endopeptidase activity GO:0004175 9.26 REN ACE
2 potassium channel activity GO:0005267 9.16 KCNMA1 KCNIP1
3 potassium channel regulator activity GO:0015459 8.96 KCNMB1 KCNIP1
4 calcium-activated potassium channel activity GO:0015269 8.62 KCNMB1 KCNMA1
Sources

Sources for Hypertension, Diastolic

About this section
3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
28 GO
29 GTR
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 LOVD
41 MedGen
43 MeSH
44 MESH via Orphanet
45 MGI
48 NCI
49 NCIt
50 NDF-RT
53 NINDS
54 Novoseek
56 OMIM
57 OMIM via Orphanet
61 PubMed
63 QIAGEN
68 SNOMED-CT via HPO
69 TGDB
70 Tocris
71 UMLS
72 UMLS via Orphanet
The MalaCards human disease database index: 1-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Content
Loading form....